Overview

A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension

Status:
Terminated
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether aspirin and simvastatin are safe and effective for the treatment of pulmonary arterial hypertension (PAH).
Phase:
Phase 2
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Aspirin
Simvastatin